Lexeo Therapeutics (LXEO) Earnings Date & Reports

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LXEO is expected to report earnings to rise 163.33% to -79 cents per share on December 14

Lexeo Therapeutics LXEO Stock Earnings Reports

Q3'26

Est.

$-0.79

Q2'26

Beat

by $0.46

Q1'26

Beat

by $0.49

Q4'25

Beat

by $0.59

Q3'25

Beat

by $0.51

The last earnings report on August 12 showed earnings per share of -30 cents, beating the estimate of -75 cents. With 636.09K shares outstanding, the current market capitalization sits at 271.71M.

View a ticker or compare two or three

LXEO

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for LXEO